These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27522498)

  • 1. Haploinsufficiency of Klippel-Trenaunay syndrome gene Aggf1 inhibits developmental and pathological angiogenesis by inactivating PI3K and AKT and disrupts vascular integrity by activating VE-cadherin.
    Zhang T; Yao Y; Wang J; Li Y; He P; Pasupuleti V; Hu Z; Jia X; Song Q; Tian XL; Hu C; Chen Q; Wang QK
    Hum Mol Genet; 2016 Dec; 25(23):5094-5110. PubMed ID: 27522498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of Klippel-Trenaunay syndrome gene AGGF1 identifies a novel angiogenic signaling pathway for specification of vein differentiation and angiogenesis during embryogenesis.
    Chen D; Li L; Tu X; Yin Z; Wang Q
    Hum Mol Genet; 2013 Mar; 22(5):963-76. PubMed ID: 23197652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel roles of GATA1 in regulation of angiogenic factor AGGF1 and endothelial cell function.
    Fan C; Ouyang P; Timur AA; He P; You SA; Hu Y; Ke T; Driscoll DJ; Chen Q; Wang QK
    J Biol Chem; 2009 Aug; 284(35):23331-43. PubMed ID: 19556247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenic Factor AGGF1 Activates Autophagy with an Essential Role in Therapeutic Angiogenesis for Heart Disease.
    Lu Q; Yao Y; Hu Z; Hu C; Song Q; Ye J; Xu C; Wang AZ; Chen Q; Wang QK
    PLoS Biol; 2016 Aug; 14(8):e1002529. PubMed ID: 27513923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor and Molecular Mechanism of AGGF1 Signaling in Endothelial Cell Functions and Angiogenesis.
    Wang J; Peng H; Timur AA; Pasupuleti V; Yao Y; Zhang T; You SA; Fan C; Yu Y; Jia X; Chen J; Xu C; Chen Q; Wang Q
    Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2756-2769. PubMed ID: 34551592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Klippel-Trénaunay Syndrome in 2022: Unravelling Its Genetic and Molecular Profile and Its Link to the Limb Overgrowth Syndromes.
    Harnarayan P; Harnanan D
    Vasc Health Risk Manag; 2022; 18():201-209. PubMed ID: 35401004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted next-generation sequencing for detection of PIK3CA mutations in archival tissues from patients with Klippel-Trenaunay syndrome in an Asian population : List the full names and institutional addresses for all authors.
    Sasaki Y; Ishikawa K; Hatanaka KC; Oyamada Y; Sakuhara Y; Shimizu T; Saito T; Murao N; Onodera T; Miura T; Maeda T; Funayama E; Hatanaka Y; Yamamoto Y; Sasaki S
    Orphanet J Rare Dis; 2023 Sep; 18(1):270. PubMed ID: 37667289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomedicine and diseases: the Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis.
    Timur AA; Driscoll DJ; Wang Q
    Cell Mol Life Sci; 2005 Jul; 62(13):1434-47. PubMed ID: 15905966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of association of common AGGF1 variants with susceptibility for Klippel-Trenaunay syndrome using the structure association program.
    Hu Y; Li L; Seidelmann SB; Timur AA; Shen PH; Driscoll DJ; Wang QK
    Ann Hum Genet; 2008 Sep; 72(Pt 5):636-43. PubMed ID: 18564129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Klippel-Trenaunay syndrome: identification of a susceptibility gene coding for an angiogenic factor].
    Dereure O
    Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 1):1037. PubMed ID: 16446658
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiogenic Factor AGGF1-Primed Endothelial Progenitor Cells Repair Vascular Defect in Diabetic Mice.
    Yao Y; Li Y; Song Q; Hu C; Xie W; Xu C; Chen Q; Wang QK
    Diabetes; 2019 Aug; 68(8):1635-1648. PubMed ID: 31092480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the E133K allele of VG5Q associated with Klippel-Trenaunay and other overgrowth syndromes?
    Barker KT; Foulkes WD; Schwartz CE; Labadie C; Monsell F; Houlston RS; Harper J
    J Med Genet; 2006 Jul; 43(7):613-4. PubMed ID: 16443853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome.
    Tian XL; Kadaba R; You SA; Liu M; Timur AA; Yang L; Chen Q; Szafranski P; Rao S; Wu L; Housman DE; DiCorleto PE; Driscoll DJ; Borrow J; Wang Q
    Nature; 2004 Feb; 427(6975):640-5. PubMed ID: 14961121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II increases angiogenesis by NF-κB-mediated transcriptional activation of angiogenic factor AGGF1.
    Si W; Xie W; Deng W; Xiao Y; Karnik SS; Xu C; Chen Q; Wang QK
    FASEB J; 2018 Sep; 32(9):5051-5062. PubMed ID: 29641288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-inducible factor-3α promotes angiogenic activity of pulmonary endothelial cells by repressing the expression of the VE-cadherin gene.
    Kobayashi S; Yamashita T; Ohneda K; Nagano M; Kimura K; Nakai H; Poellinger L; Ohneda O
    Genes Cells; 2015 Mar; 20(3):224-41. PubMed ID: 25626335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS).
    Vahidnezhad H; Youssefian L; Uitto J
    Exp Dermatol; 2016 Jan; 25(1):17-9. PubMed ID: 26268729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
    Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
    Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
    Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AGGF1 is a novel anti-inflammatory factor associated with TNF-α-induced endothelial activation.
    Hu FY; Wu C; Li Y; Xu K; Wang WJ; Cao H; Tian XL
    Cell Signal; 2013 Aug; 25(8):1645-53. PubMed ID: 23628701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial PI3K-C2α, a class II PI3K, has an essential role in angiogenesis and vascular barrier function.
    Yoshioka K; Yoshida K; Cui H; Wakayama T; Takuwa N; Okamoto Y; Du W; Qi X; Asanuma K; Sugihara K; Aki S; Miyazawa H; Biswas K; Nagakura C; Ueno M; Iseki S; Schwartz RJ; Okamoto H; Sasaki T; Matsui O; Asano M; Adams RH; Takakura N; Takuwa Y
    Nat Med; 2012 Oct; 18(10):1560-9. PubMed ID: 22983395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.